National Institutes of Health

Description

Type 1 Diabetes TrialNet is an international consortium of clinical research centers aimed at the delay or prevention of type 1 diabetes (T1D). This opportunity will provide infrastructure support for TrialNet Clinical Centers, allowing them to recruit, treat, and follow subjects in TrialNet studies and trials. In addition, funding will be provided for Clinical Centers to support Affiliate Sites. In addition to this opportunity, a separate, new TrialNet unit is planned, the Clinical Network Hub (CNH). The CNH will focus on the coordination and enhancement of screening and recruiting activities.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV